Anti-Obesity Prescription Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

1
Anti-Obesity Prescription Drugs Market Global
Industry Analysis, Trends, Market Size and
Forecasts up to 2024
2
The report on Anti-Obesity Prescription Drugs
Market by drug class (orlistat, phentermine and
topiramate, bupropion and naltrexone,
lorcaserin, liraglutide), distribution channel
(retail pharmacy, hospital pharmacy and online
pharmacy), age group (pediatric and adult) trends
analysis and forecasts up to 2024 studies the
market sizes, key trends and opportunities in the
main geographies such as North America, Europe,
Asia- Pacific, Rest of the World. According to
the report the Global Anti-Obesity Prescription
Drugs Market is projected to grow at a CAGR of
4.97 in terms of value over the period of
2018-2024. The growth in the world market is
primarily driven by significant contribution by
North America (Leading region) region to this
market. Get a Sample Request https//www.infinium
globalresearch.com/reports/sample_request/1127 Ma
rket Insight The pharmacological agents that
helps to reduce or control weight. Anti-obesity
drugs help in reducing body mass either by
reducing the hunger or increasing the consumption
of calories. The ingesting of unhealthy food
which is rich in cholesterol has increased which
leads to a rise in demand for anti-obesity
prescription drugs. Rising level of chronic
stress also contributes towards obesity.Rising
consumption of alcoholic beverages and unhealthy
food which is rich in cholesterol that leads to
obesity is driving the growth of the market.
Growing occurrence of depression has led to
growing consumption of the psychotropic drugs
the side effect of this drug is increasing which
result to obesity. Moreover, increasing
incidences of diabetes have surged up the
consumption of medications. These medications
have appetite stimulating features, due to which
the patients incline to eat more. Eating
disorders due to antidepressants and diabetic
drugs increase the diet which has sustained to
contribute towards obesity. Growing demand for
obesity management is expected to impact growth
of the global anti-obesity prescription drugs
market positively.
3
Segment Covered The report on global anti-obesity
prescription drugs market covers segments such
as, drug class, distribution channel and age
group. On the basis of drug class the global
anti-obesity prescription drugs market is
categorized into orlistat, phentermine and
topiramate, bupropion and naltrexone, lorcaserin
and liraglutide. On the basis of distribution
channel the global anti-obesity prescription
drugs market is categorized into retail
pharmacy, hospital pharmacy and online pharmacy.
On the basis of age group the global anti-obesity
prescription drugs market is categorized into
pediatric and adult. Make an Enquiry
https//www.infiniumglobalresearch.com/reports/enq
uiry/1127 Geographic Coverage The report
provides regional analysis covering geographies
such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key trends
and market size for each geography is provided
over the period of 2016-2024. The countries
covered in the North America region include the
U.S., Canada, and Mexico while Asia-Pacific
includes China, Japan, India, South Korea,
Malaysia, and among others. Moreover, Germany,
U.K., France, Spain, and Rest of Europe are
included in the European region. The U.S. drives
the growth in the North America region as it is
the largest market in the region. The
Asia-pacific region offers a substantial
potential for the market growth owing to rapid
growth in markets such as India and China.
Countries such as the U.S., the U.K., and France
among others have reported substantial rise in
the obesity population. Moreover, growing work
stress in emerging markets of Asia-pacific is
likely to cause rise in obesity cases in
the years to come over the next six years.
According to the study North America followed by
Europe accounted for the largest market share in
the word anti-obesity prescription drugs market
in 2016 and this trend is projected to continue
over the forecast period, with increasing
awareness among the people in the U.S. and Canada.
4
Companies Profiled The report provides profiles
of the companies in the global anti-obesity
prescription drugs market such as, F Hoffmann La
Roche Ltd, Orexigen Therapeutics, Inc, Novo
Nordisk A/S, Arena Pharmaceuticals, Inc,
GlaxoSmithKline, VIVUS, Inc, Boehringer
Ingelheim, Alizyme and Others. Recently approved
Saxenda by Novo Nordisk is growing at a fast
growth rate due to rising interest among obese
people.Novo Nordisk, an innovator of drugs in
the obesity market, introduces Saxenda in all the
major markets with a higher dose of glucagon-like
peptide-1 (GLP-1) receptor agonist, liraglutide,
This Dual therapy can be used for both obesity
and type 2 diabetes is the latest trend in the
market. Click the Below Full Report Link
https//www.infiniumglobalresearch.com/healthcare_
medical_devices/global_anti- obesity_prescription
_drugs_market Report Highlights The report
provides deep insights on demand forecasts,
market trends and micro and macro indicators. In
addition, this report provides insights on the
factors that are driving and restraining the
global anti-obesity prescription drugs market.
Moreover, IGR-Growth Matrix analysis given in the
report brings an insight on the investment areas
that existing or new market players can consider.
The report provides insights into the market
using analytical tools such as Porter's five
forces analysis and DRO analysis of anti-obesity
prescription drugs market. Moreover, the study
highlights current market trends and provides
forecast from 2018-2024. We also have
highlighted future trends in the anti-obesity
prescription drugs market that will impact the
demand during the forecast period. Moreover, the
competitive analysis given in each regional
market brings an insight on the market share of
the leading players. This report will help
manufacturers, suppliers and distributors of the
anti- obesity prescription drugs market to
understand the present and future trends in this
market and formulate their strategies
accordingly.